Banner

Typhoid Vi Polysaccharide Vaccine Global Market Report 2023 – By Type (Child, Adult), By Route of Administration (Oral, Parenteral), By Application (Government Institution, Private Sector, Other Applications) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : | Delivery Time: 2-3 business days | Format :


Typhoid Vi polysaccharide vaccine refers to the recommendation of active immunization for people aged two and up, concerning the prevention of typhoid fever caused by Salmonella typhi.

 

The main types of typhoid Vi polysaccharide vaccine are child and adult. A child is a person between birth and puberty, or full growth. The routes of administration for this vaccine include oral and parenteral and are applied in government institutions, the private sector, and others.

 

The typhoid Vi polysaccharide vaccine market research report is one of a series of new reports from The Business Research Company that provides typhoid Vi polysaccharide vaccine market statistics, including typhoid Vi polysaccharide vaccine industry global market size, regional shares, competitors with typhoid Vi polysaccharide vaccine market share, detailed typhoid Vi polysaccharide vaccine market segments, market trends and opportunities, and any further data you may need to thrive in typhoid Vi polysaccharide vaccine industry. This Typhoid Vi polysaccharide vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global typhoid Vi polysaccharide vaccine market size is expected to grow from $4.23 billion in 2022 to $4.96 billion in 2023 at a compound annual growth rate (CAGR) of 17.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The typhoid Vi polysaccharide vaccine market is expected to grow to $9.20 billion in 2027 at a CAGR of 16.7%.

Rising typhoid prevalence is expected to propel the growth of the typhoid VI polysaccharide vaccine market going forward. Typhoid is an infection caused by the bacteria Salmonella typhi that can be fatal. It usually spreads through contaminated food or drink. Typhoid Vi polysaccharide vaccine is used to immunise adults and children aged 2 and up against typhoid fever caused by Salmonella enterica serovar Typhi, S. Typhi. For instance, in March 2021, according to a report shared by the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, infections with Salmonella Typhi were believed to affect 5,700 Americans annually, with 620 of these likely to require hospitalization. Typhoid fever mostly causes between 11 and 21 million cases worldwide every year, along with 200,000 fatalities. Therefore, the rising typhoid prevalence is driving the growth of the typhoid Vi polysaccharide vaccine market.

Strategic partnerships are a key trend gaining popularity in the typhoid Vi polysaccharide vaccine market. Major companies operating in the typhoid Vi polysaccharide vaccine market are entering into partnerships to strengthen their position in the typhoid Vi polysaccharide market. For instance, in July 2022, The International Vaccine Institute, a South Korea-based international organization focused on infectious diseases of global health importance such as cholera, typhoid, shigella, and salmonella, partnered with Moderna, a US-based biopharmaceutical company. This partnership led to the world’s first affordable oral cholera vaccine and a new-generation typhoid conjugate vaccine. Further, in December 2020, Biological E, an India-based biotechnology and biopharmaceutical company, collaborated with the GSK Vaccines Institute for Global Health (GVGH), a UK-based research and development center operating in the typhoid Vi polysaccharide vaccine. This collaboration is for the development of a typhoid conjugate vaccine (TCV)

Growing expenditure in the healthcare sector is expected to propel the growth of the typhoid Vi polysaccharide vaccine market going forward. Healthcare expenditure refers to the overall cost of health care (including public and private expenditures) as a percentage of GDP. Rising healthcare expenditure helps typhoid Vi polysaccharide vaccine manufacturers develop more typhoid vaccines, which increase the demand for the typhoid Vi polysaccharide vaccine market. For instance, according to the Organisation for Economic Co-operation and Development, a France-based intergovernmental economic organization, in 2020 health spending as a share of GDP jumped to 9.7% across OECD countries, up from 8.8% in the previous year. A group of 17 OECD countries suggests that health spending continued to grow strongly in 2021 by around 6%. Therefore, growing expenditure in the healthcare sector is driving the growth of the typhoid Vi polysaccharide vaccine market.

Major players in the typhoid vi polysaccharide vaccine market are Sanofi Pasteur SA, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson Private Limited, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, EMERGENT, PT Bio Farma, Bharat Biotech International Limited, Teva Pharmaceutical Industries Ltd., Novartis AG, and Mylan N.V.

Asia-Pacific was the largest region in the typhoid Vi polysaccharide vaccine market in 2022. The regions covered in the typhoid Vi polysaccharide vaccine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the typhoid Vi polysaccharide vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The typhoid Vi polysaccharide vaccine market consists of sales of Vi capsular polysaccharide vaccine, and non-conjugated Vi polysaccharide vaccine,. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global typhoid VI polysaccharide vaccine market is segmented -

1) By Type: Child, Adult

2) By Route of Administration: Oral, Parenteral

3) By Application: Government Institutions, Private Sector, Other Applications

    Table Of Contents

    1. Executive Summary

    2. Typhoid Vi Polysaccharide Vaccine Market Characteristics

    3. Typhoid Vi Polysaccharide Vaccine Market Trends And Strategies

    4. Typhoid Vi Polysaccharide Vaccine Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Typhoid Vi Polysaccharide Vaccine Market

    4.2. Ukraine-Russia War Impact On Typhoid Vi Polysaccharide Vaccine Market

    4.3. Impact Of High Inflation On Typhoid Vi Polysaccharide Vaccine Market

    5. Typhoid Vi Polysaccharide Vaccine Market Size And Growth

    5.1. Global Typhoid Vi Polysaccharide Vaccine Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Typhoid Vi Polysaccharide Vaccine Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Typhoid Vi Polysaccharide Vaccine Market Segmentation

    6.1. Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Child

    Adult

    6.2. Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Oral

    Parenteral

    6.3. Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Government Institution

    Private Sector

    Other Applications

    7. Typhoid Vi Polysaccharide Vaccine Market Regional And Country Analysis

    7.1. Global Typhoid Vi Polysaccharide Vaccine Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Typhoid Vi Polysaccharide Vaccine Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market

    8.1. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Typhoid Vi Polysaccharide Vaccine Market

    9.1. China Typhoid Vi Polysaccharide Vaccine Market Overview

    9.2. China Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Typhoid Vi Polysaccharide Vaccine Market

    10.1. India Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Typhoid Vi Polysaccharide Vaccine Market

    11.1. Japan Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Typhoid Vi Polysaccharide Vaccine Market

    12.1. Australia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Typhoid Vi Polysaccharide Vaccine Market

    13.1. Indonesia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Typhoid Vi Polysaccharide Vaccine Market

    14.1. South Korea Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Typhoid Vi Polysaccharide Vaccine Market

    15.1. Western Europe Typhoid Vi Polysaccharide Vaccine Market Overview

    15.2. Western Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Typhoid Vi Polysaccharide Vaccine Market

    16.1. UK Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Typhoid Vi Polysaccharide Vaccine Market

    17.1. Germany Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Typhoid Vi Polysaccharide Vaccine Market

    18.4. France Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market

    19.1. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market Overview

    19.2. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Typhoid Vi Polysaccharide Vaccine Market

    20.1. Russia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Typhoid Vi Polysaccharide Vaccine Market

    21.1. North America Typhoid Vi Polysaccharide Vaccine Market Overview

    21.2. North America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Typhoid Vi Polysaccharide Vaccine Market

    22.1. USA Typhoid Vi Polysaccharide Vaccine Market Overview

    22.2. USA Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Typhoid Vi Polysaccharide Vaccine Market

    23.1. South America Typhoid Vi Polysaccharide Vaccine Market Overview

    23.2. South America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Typhoid Vi Polysaccharide Vaccine Market

    24.1. Brazil Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Typhoid Vi Polysaccharide Vaccine Market

    25.1. Middle East Typhoid Vi Polysaccharide Vaccine Market Overview

    25.2. Middle East Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Typhoid Vi Polysaccharide Vaccine Market

    26.1. Africa Typhoid Vi Polysaccharide Vaccine Market Overview

    26.2. Africa Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Typhoid Vi Polysaccharide Vaccine Market Competitive Landscape And Company Profiles

    27.1. Typhoid Vi Polysaccharide Vaccine Market Competitive Landscape

    27.2. Typhoid Vi Polysaccharide Vaccine Market Company Profiles

    27.2.1. Sanofi Pasteur SA

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. GlaxoSmithKline plc

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Merck & Co. Inc.

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Pfizer Inc.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Johnson & Johnson Private Limited

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Typhoid Vi Polysaccharide Vaccine Market

    29. Typhoid Vi Polysaccharide Vaccine Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Sanofi Pasteur SA Financial Performance
  • Table 47: GlaxoSmithKline plc Financial Performance
  • Table 48: Merck & Co. Inc. Financial Performance
  • Table 49: Pfizer Inc. Financial Performance
  • Table 50: Johnson & Johnson Private Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Sanofi Pasteur SA Financial Performance
  • Figure 47: GlaxoSmithKline plc Financial Performance
  • Figure 48: Merck & Co. Inc. Financial Performance
  • Figure 49: Pfizer Inc. Financial Performance
  • Figure 50: Johnson & Johnson Private Limited Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report